Cathay Biotech Inc. (SHA:688065)

China flag China · Delayed Price · Currency is CNY
46.55
-0.44 (-0.94%)
Apr 28, 2026, 3:00 PM CST
-10.99%
Market Cap 33.55B
Revenue (ttm) 3.30B
Net Income (ttm) 560.72M
Shares Out 720.66M
EPS (ttm) 0.82
PE Ratio 56.77
Forward PE 39.45
Dividend 0.40 (0.85%)
Ex-Dividend Date Aug 1, 2025
Volume 4,471,174
Average Volume 4,113,844
Open 47.00
Previous Close 46.99
Day's Range 46.10 - 47.60
52-Week Range 45.00 - 64.50
Beta 0.71
RSI 37.56
Earnings Date Apr 24, 2026

About Cathay Biotech

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company’s products are used in textiles, pharmaceuticals, perfumes, aut... [Read more]

Industry Chemicals
Sector Materials
Founded 2000
Employees 1,764
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688065
Full Company Profile

Financial Performance

In 2025, Cathay Biotech's revenue was 3.30 billion, an increase of 11.40% compared to the previous year's 2.96 billion. Earnings were 560.72 million, an increase of 14.68%.

Financial Statements

News

There is no news available yet.